Biotechnology - Neurological, Hematology


Current filters:


Popular Filters

1 to 25 of 2898 results

Biogen Idec 1st-qtr 2014 revenue leaps 51%, driven by Tecfidera and MS franchise


US biotech firm Biogen Idec first-quarter 2014 results today, including revenue of $2.1 billion, a 51%…

Biogen IdecBiotechnologyFinancialNeurologicalResearchTecfidera

IQWiG finds added benefit for Novo Nordisk’s NovoEight not proven


In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

GermanyHematologyNorthern EuropeNovo NordiskNovoEightPharmaceuticalPricingRegulation

Amgen's 1st-qtr 2014 disappoints, as net income falls 25%


Amgen, the world’s largest independent biotech firm by revenues, yesterday announced financial results…


Bristol-Myers Squibb and Samsung BioLogics expand manufacturing deal


US drug major Bristol-Myers Squibb and South Korea’s Samsung BioLogics revealed that they will increase…

Asia-PacificBiotechnologyBristol-Myers SquibbProductionSamsung BioLogics

Gilead 1st-qtr 2014 sales nearly double, fuelled by Sovaldi, as net income rockets


US antivirals major Gilead Sciences posted first-quarter 2014 results after markets closed yesterday,…

Anti-viralsBiotechnologyFinancialGilead SciencesSovaldi

Epizyme earns $4 million milestone under GSK collaboration


US clinical-stage biopharma firm Epizyme announced the achievement of the lead candidate milestone for…


AusBiotech to submit to Senate’s Australian innovation system inquiry


Trade group AusBiotech is preparing a submission, following the Senate's referral of an inquiry into…


Sentinel Oncology in deal with Oncothyreon worth a potential $174 million


UK-based small molecule drug discovered Sentinel Oncology has signed a collaboration agreement with the…

BiotechnologyLicensingOncologyOncothyreonResearchSentinel Oncology

Sanofi divests Cell Therapy and Regenerative Medicine business to Aastrom


US cardiovascular drug developer Aastrom Biosciences has entered into a definitive agreement to acquire…

Aastrom BiosciencesBiotechnologyMergers & AcquisitionsSanofi

US FDA clears pathway for Sarepta’s eteplirsen filing by year end


US RNA-based drug developer Sarepta Therapeutics it plans to submit a New Drug Application to the US…

BiotechnologyeteplirsenNorth AmericaRare diseasesRegulationSarepta TherapeuticsUSA

US Supreme Court denies Teva's request for injunction relating to Mylan’s generic Copaxone


The US Supreme Court Chief Justice Roberts has denied Israeli generics giant Teva Pharmaceutical Industries’…

CopaxoneGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaPatentsTeva Pharmaceutical IndustriesUSA

Biogen Idec exercises option for Amunix’ XTENylated Factor VIII


US privately-held biotech firm Amunix Operating says that Biogen Idec has exercised its option to enter…

AmunixBiogen IdecBiotechnologyHematologyLicensing

NHS England agrees funding for Gilead’s hepatitis C drug Sovaldi


NHS England has approved an £18.7 million ($31.3 million) investment in a new drug for the treatment…

Anti-viralsBiotechnologyFinancialGilead SciencesHealthcareNorthern EuropeSovaldiUK

First Asian approval for ophthalmic drug Jetrea, in Malaysia


Belgian biotech firm ThromboGenics NV revealed today that Jetrea (ocriplasmin) has been approved in Malaysia…


Baxter’s BAX 111 meets Ph III primary efficacy endpoint for VWF patients

Baxter’s BAX 111 meets Ph III primary efficacy endpoint for VWF patients


US health care company Baxter International as released encouraging top-line results from a Phase III…

BAX 111Baxter InternationalHematologyPharmaceuticalResearch

Actelion posts strong first-quarter 2014 results

Actelion posts strong first-quarter 2014 results


Switzerland’s Actelion today announced financial results for the first three months of 2014, showing…


Epirus to acquire Zalicus, creating a publicly-traded biosimilars enterprise


Boston-based privately-held Epirus Biopharmaceuticals, focused on the global development and commercialization…

BiosimilarsBiotechnologyEPIRUS BiopharmaceuticalsMergers & AcquisitionsZalicus

Bio-Techne to acquire China’s PrimeGene


Techne Corp (d/b/a Bio-Techne) says that its R&D Systems China subsidiary has entered into an agreement…

Bio-TechneBiotechnologyMergers & AcquisitionsPrimeGene Bio-Tech

New report finds upturn in the Swiss biotech sector in 2013


The Swiss biotech sector saw increases in terms of net sales, capital investments and number of employees,…

BiotechnologyBusiness FinanceBusiness FinanceEnvironmentHelvetiiMarkets & MarketingNorthern EuropeSwitzerland

Depomed settlements with two Gralise ANDA filers


US specialty drugmaker Depomed has entered into settlement agreements with two of the three defendants…

DepomedGenericsGraliseIncepta PharmaceuticalsLegalNeurologicalNorth AmericaPatentsUSAZydus Cadila

1 to 25 of 2898 results

Back to top